A resource for the UCSF cancer clinical research community during the COVID-19 pandemic.
This page is for faculty, research staff (CRCs, CRMs, PPMs, regulatory and protocol development), nurses, pharmacists, practice coordinators and managers, infusion, and leadership to address any urgent issues regarding clinical research at HDFCCC.
For questions related to clinical research operations during the COVID-19 outbreak, please reach out to Dr. Babis Andreadis (Medical Director, Clinical Research Support Office) or Andrea Skafel (Clinical Research Support Office Director)
Additional UCSF Links on Coronavirus
Important Links for HDFCCC Clinical Research Team
- UCSF IRB
- UCSF Health Investigational Drug Pharmacy
- UCSF Office of Research
- CTEP
- HDFCCC workflows
- COVID-19 Interim Policy regarding In Person Visits for Patients Starting Treatment on Interventional Therapeutic Trials (12/23/20)
- Use of DocuSign during the COVID-19 pandemic (10/29/20)
- Monitoring (6/15/20)
- HDFCCC COVID-19 Clinical Research Recovery Guidelines (5/14/20)
- HDFCCC Sponsors Monitors Monitoring Visits
- HDFCCC Policy on UCSF IRB COVID Forms (1/27/21)
- HDFCCC Sponsors Monitors Vaccines (1/8/21)
- Regulatory agencies
Newsletters
Updates regarding cancer clinical research workflow as well as any urgent issues regarding clinical research.
General Research Links
UCSF:- Guidance for Researchers (UCSF)
- Coronavirus & COVID-19 Research (UCSF-only online discussion forum for sharing published information, current research, ideas and new potential research avenues related to Coronoavirus and Covid-19 science and research)
- COVID-19 Guidance for UCSF Researchers (CTSI at UCSF)
- Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic (FDA)
- Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding (NIH)